Common Stock, Shares, Issued of Seres Therapeutics, Inc. from Q4 2014 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Seres Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and change rate from Q4 2014 to Q3 2025.
  • Seres Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 8.76M shares, a 94.9% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Seres Therapeutics, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 8.76M -161M -94.9% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 8.75M -143M -94.2% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 8.73M -143M -94.2% 31 Mar 2025 10-Q 07 May 2025
Q4 2024 8.65M -126M -93.6% 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 170M +41.6M +32.3% 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 152M +23.6M +18.4% 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 151M +24.8M +19.6% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 135M +9.82M +7.84% 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 129M +4.22M +3.39% 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 128M +35.7M +38.7% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 127M +34.4M +37.3% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 125M +33.3M +36.3% 31 Dec 2022 8-K 15 Aug 2024
Q3 2022 124M +32.6M +35.5% 30 Sep 2022 10-Q 02 Nov 2022
Q2 2022 92.3M +593K +0.65% 30 Jun 2022 10-Q 03 Aug 2022
Q1 2022 92.2M +622K +0.68% 31 Mar 2022 10-Q 04 May 2022
Q4 2021 91.9M +430K +0.47% 31 Dec 2021 10-K 07 Mar 2023
Q3 2021 91.8M +627K +0.69% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 91.7M +16.6M +22.1% 30 Jun 2021 10-Q 03 Aug 2021
Q1 2021 91.6M +19.9M +27.8% 31 Mar 2021 10-Q 04 May 2021
Q4 2020 91.5M +21.3M +30.4% 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 91.2M +21.2M +30.3% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 75.1M +5.22M +7.46% 30 Jun 2020 10-Q 28 Jul 2020
Q1 2020 71.7M +30.6M +74.4% 31 Mar 2020 10-Q 07 May 2020
Q4 2019 70.1M +29.2M +71.3% 31 Dec 2019 10-K 02 Mar 2021
Q3 2019 70M +29.1M +71.4% 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 69.9M +29.2M +71.5% 30 Jun 2019 10-Q 06 Aug 2019
Q1 2019 41.1M +442K +1.09% 31 Mar 2019 10-Q 02 May 2019
Q4 2018 40.9M +366K +0.9% 31 Dec 2018 10-K 02 Mar 2020
Q3 2018 40.8M +332K +0.82% 30 Sep 2018 10-Q 08 Nov 2018
Q2 2018 40.8M +343K +0.85% 30 Jun 2018 10-Q 02 Aug 2018
Q1 2018 40.7M +266K +0.66% 31 Mar 2018 10-Q 09 May 2018
Q4 2017 40.6M +215K +0.53% 31 Dec 2017 10-K 06 Mar 2019
Q3 2017 40.5M +157K +0.39% 30 Sep 2017 10-Q 08 Nov 2017
Q2 2017 40.4M +553K +1.39% 30 Jun 2017 10-Q 03 Aug 2017
Q1 2017 40.4M +1.17M +2.98% 31 Mar 2017 10-Q 04 May 2017
Q4 2016 40.4M +1.27M +3.26% 31 Dec 2016 10-K 08 Mar 2018
Q3 2016 40.4M +1.3M +3.33% 30 Sep 2016 10-Q 10 Nov 2016
Q2 2016 39.9M +9.44M +31% 30 Jun 2016 10-Q 11 Aug 2016
Q1 2016 39.2M 31 Mar 2016 10-Q 16 May 2016
Q4 2015 39.1M +32.2M +467% 31 Dec 2015 10-K 16 Mar 2017
Q3 2015 39.1M 30 Sep 2015 10-Q 12 Nov 2015
Q2 2015 30.4M 30 Jun 2015 10-Q 10 Aug 2015
Q4 2014 6.89M 31 Dec 2014 10-K 14 Mar 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.